{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:34:23Z","timestamp":1791326063670,"version":"4.3.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":792,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>The human hepatitis B virus (HBV) causes acute and chronic infections in humans and chimpanzees. HBV infects its hosts at minimal inoculation doses and replicates exclusively in hepatocytes. The viral determinants for the pronounced species specificity and the high efficacy to address hepatocytes <jats:italic toggle=\"yes\">in vivo<\/jats:italic> are unknown. Previous findings showed that N-terminally myristoylated peptides constituting a receptor binding domain of the HBV large envelope (L)-protein block HBV entry <jats:italic toggle=\"yes\">in vitro<\/jats:italic> and <jats:italic toggle=\"yes\">in vivo<\/jats:italic>. Here we investigate the ability of such peptidic receptor ligands to target the liver. Injection of radioactively labeled HBVpreS-lipopeptides resulted in rapid accumulation in livers of mice, rats, and dogs but not cynomolgus monkeys. Without lipid moiety the peptide was excreted by renal filtration, indicating its possible retention through the lipid by serum factors. Organ distribution studies of 26 HBVpreS peptide variants revealed a correlation of HBV infection inhibition activity and the ability to target mouse livers. Together with complementary studies using primary hepatocytes of different species, we hypothesize that HBV hepatotropism is mediated through specific binding of the myristoylated N-terminal preS1-domain of the HBV L-protein to a hepatocyte specific receptor. Moreover, the restricted infectivity of HBV to human primates is not generally determined by the absence of this binding receptor in nonsusceptible hosts (e.g., mice) but related to postbinding step(s) (e.g., membrane fusion). <jats:bold>\n                                    Conclusion\n                                 <\/jats:bold>: HBVpreS-lipopeptides target to the liver. This observation has important clinical implications regarding the pharmacokinetic properties of Myrcludex B, the first entry inhibitor for HBV\/HDV. In addition, this provides the basis for the application of the peptides as vehicles for hepatocyte-specific drug targeting. (HEPATOLOGY 2013)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26211","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T20:04:33Z","timestamp":1357329873000},"page":"43-53","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":105,"title":["Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts"],"prefix":"10.1097","volume":"58","author":[{"given":"Alexa","family":"Schieck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"G\u00e4hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Alexandrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Mier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20241201","first-page":"451","article-title":"Treatment of chronic hepatitis B.","volume":"56","author":"Cornberg","year":"2010","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R2-10-20241201","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues.","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"},{"key":"R3-10-20241201","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","article-title":"Hepatitis B virus biology.","volume":"64","author":"Seeger","year":"2000","journal-title":"Microbiol Mol Biol Rev"},{"key":"R4-10-20241201","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3748\/wjg.v13.i1.65","article-title":"Hepatitis B virus morphogenesis.","volume":"13","author":"Bruss","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R5-10-20241201","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","article-title":"Hepatitis B virus infection initiates with a large surface proteindependent binding to heparan sulfate proteoglycans.","volume":"46","author":"Schulze","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R6-10-20241201","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/hep.21112","article-title":"Characterization of a hepatitis B and hepatitis delta virus receptor binding site.","volume":"43","author":"Engelke","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R7-10-20241201","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/JVI.79.3.1613-1622.2005","article-title":"Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.","volume":"79","author":"Gripon","year":"2005","journal-title":"J Virol"},{"key":"R8-10-20241201","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1128\/JVI.73.3.2052-2057.1999","article-title":"Infection process of the hepatitis B virus depends on the presence of a defined sequence in the preS1 domain.","volume":"73","author":"LeSeyec","year":"1999","journal-title":"J Virol"},{"key":"R9-10-20241201","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/viro.1995.0002","article-title":"Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity.","volume":"213","author":"Gripon","year":"1995","journal-title":"Virology"},{"key":"R10-10-20241201","doi-asserted-by":"crossref","first-page":"12443","DOI":"10.1128\/JVI.01594-09","article-title":"The preS1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent.","volume":"83","author":"LeDuff","year":"2009","journal-title":"J Virol"},{"key":"R11-10-20241201","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1128\/JVI.00096-07","article-title":"Infectivity determinants of the hepatitis B virus preS domain are confined to the Nterminal 75 amino acid residues.","volume":"81","author":"Blanchet","year":"2007","journal-title":"J Virol"},{"key":"R12-10-20241201","first-page":"122","article-title":"Role of glycosaminoglycans for binding and infection of hepatitis B virus.","volume":"10","author":"Leistner","year":"2008","journal-title":"Cell Microbiol"},{"key":"R13-10-20241201","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1128\/JVI.77.17.9511-9521.2003","article-title":"Pres1 antigendependent infection of Tupaia hepatocyte cultures with human hepatitis B virus.","volume":"77","author":"Glebe","year":"2003","journal-title":"J Virol"},{"key":"R14-10-20241201","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection.","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-10-20241201","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jhep.2009.10.031","article-title":"The replication cycle of hepatitis B virus.","volume":"52","author":"Urban","year":"2010","journal-title":"J Hepatol"},{"key":"R16-10-20241201","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.1128\/JVI.00867-09","article-title":"The size of the viral inoculum contributes to the outcome of hepatitis B virus infection.","volume":"83","author":"Asabe","year":"2009","journal-title":"J Virol"},{"key":"R17-10-20241201","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus.","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-10-20241201","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/978-1-60761-688-7_25","article-title":"The use of hepatocytes to investigate HDV infection: the HDVHepaRG model.","volume":"640","author":"Sureau","year":"2010","journal-title":"Methods Mol Biol"},{"key":"R19-10-20241201","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2005.03.090","article-title":"Mapping of the hepatitis B virus attachment site by use of infectioninhibiting preS1 lipopeptides and tupaia hepatocytes.","volume":"129","author":"Glebe","year":"2005","journal-title":"Gastroenterology"},{"key":"R20-10-20241201","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/JVI.01902-09","article-title":"Fine mapping of preS sequence requirements for hepatitis B virus large envelope proteinmediated receptor interaction.","volume":"84","author":"Schulze","year":"2010","journal-title":"J Virol"},{"key":"R21-10-20241201","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nbt1389","article-title":"Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.","volume":"26","author":"Petersen","year":"2008","journal-title":"Nat Biotechnol"},{"key":"R22-10-20241201","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/hep.26181","article-title":"Myristoylated PreS1domain of the hepatitis B virus Lprotein mediates specific binding to differentiated hepatocytes.","volume":"58","author":"Meier","year":"2013","journal-title":"HEPATOLOGY"},{"key":"R23-10-20241201","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.3390\/molecules15074773","article-title":"Solidphase synthesis of the lipopeptide MyrHBVpreS278, a hepatitis B virus entry inhibitor.","volume":"15","author":"Schieck","year":"2010","journal-title":"Molecules"},{"key":"R24-10-20241201","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0196-9781(02)00192-4","article-title":"Approaches to radioiodination of insect neuropeptides.","volume":"23","author":"Crim","year":"2002","journal-title":"Peptides"},{"key":"R25-10-20241201","doi-asserted-by":"crossref","first-page":"9786","DOI":"10.1128\/JVI.79.15.9786-9798.2005","article-title":"Mapping of the hepatitis B virus preS1 domain involved in receptor recognition.","volume":"79","author":"Barrera","year":"2005","journal-title":"J Virol"},{"key":"R26-10-20241201","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/psc.430","article-title":"The aspartimide problem in Fmocbased SPPS. Part I.","volume":"9","author":"Mergler","year":"2003","journal-title":"J Pept Sci"},{"key":"R27-10-20241201","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/1091581810378896","article-title":"Developmental toxicity testing of biopharmaceuticals in nonhuman primates: previous experience and future directions.","volume":"29","author":"Martin","year":"2010","journal-title":"Int J Toxicol"},{"key":"R28-10-20241201","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.23602","article-title":"Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model.","volume":"51","author":"Lucifora","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R29-10-20241201","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2003-37583","article-title":"Epidemiology and prevention of hepatitis B.","volume":"23","author":"Alter","year":"2003","journal-title":"Semin Liver Dis"},{"key":"R30-10-20241201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.510240101","article-title":"Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo.","volume":"24","author":"Walter","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R31-10-20241201","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.24758","article-title":"Humananized chimeric uPA mouse model to study hepatitis B and D virus interactions and preclinical drug evaluation.","volume":"55","author":"Lutgehetmann","year":"2012","journal-title":"HEPATOLOGY"},{"key":"R32-10-20241201","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2006-939760","article-title":"Small animal model systems for studying hepatitis B virus replication and pathogenesis.","volume":"26","author":"Dandri","year":"2006","journal-title":"Semin Liver Dis"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26211","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201307000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:12:58Z","timestamp":1733062378000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201307000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26211","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}